A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT02538536 · COMPLETED
Trial details
- NCT number
- NCT02538536
- Sponsor
- Liminal BioSciences Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-01-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.